Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM)
Status:
Unknown status
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the short term use of indomethacin will reduce
the number of women delivering within 48 hours when given to women with preterm premature
rupture of membranes (PPROM) between 24- 32 weeks of gestation. We hypothesize that
indomethacin's anti-inflammatory and tocolytic action will reduce the number of women
delivering within 48 hours when given to women with PPROM between 24-32 weeks of gestation.